Enzo Biochem, Inc. ' Product Pipeline Review ' 2012

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Enzo Biochem, Inc. ' Product Pipeline Review ' 2012
Published on August 2012

Report Summary


Summary

Global Markets Direct's pharmaceuticals report, 'Enzo Biochem, Inc. - Product Pipeline Review - 2012' provides data on the Enzo
Biochem, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with
latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Enzo Biochem, Inc.'s
corporate website, SEC filings, investor presentations and featured press releases, both from Enzo Biochem, Inc. and
industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Enzo Biochem, Inc. - Brief Enzo Biochem, Inc. overview including business description, key information and facts, and its locations
and subsidiaries.
- Review of current pipeline of Enzo Biochem, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities,
across the globe.
- Product profiles for late stage and clinical stage products of Enzo Biochem, Inc. with complete description of the product's
developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Enzo Biochem, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Enzo Biochem, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Enzo Biochem, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Enzo Biochem, Inc.'s R&D portfolio and develop key strategic initiatives to
reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Enzo Biochem, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Enzo Biochem, Inc. and identify potential opportunities in those areas.

Enzo Biochem, Inc. ' Product Pipeline Review ' 2012 (From Slideshare) Page 1/7


Table of Content

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Enzo Biochem, Inc. Snapshot 6
Enzo Biochem, Inc. Overview 6
Key Information 6
Key Facts 6
Enzo Biochem, Inc. ' Research and Development Overview 7
Key Therapeutic Areas 7
Enzo Biochem, Inc. ' Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products ' Monotherapy 10
Enzo Biochem, Inc. ' Pipeline Products Glance 11
Enzo Biochem, Inc. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Enzo Biochem, Inc. ' Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Enzo Biochem, Inc. ' Drug Profiles 14
Alequel 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Drug For Diabetes 15
R&D Progress 15
Drug For Osteonecrosis Of Jaws 16
R&D Progress 16
Drug For Osteoporosis 17
R&D Progress 17
Drugs For Cancer 18
R&D Progress 18
Enzo-D58 19
R&D Progress 19



HGTV43 20
R&D Progress 20
Optiquel 21
R&D Progress 21
Enzo Biochem, Inc. ' Pipeline Analysis 23
Enzo Biochem, Inc. ' Pipeline Products by Therapeutic Class 23
Enzo Biochem, Inc. ' Pipeline Products by Route of Administration 24
Enzo Biochem, Inc. ' Recent Pipeline Updates 25
Enzo Biochem, Inc. - Dormant Projects 26
Enzo Biochem, Inc. - Discontinued Pipeline Products 27
Discontinued Pipeline Product Profiles 27
EHT899 27
Enzo Biochem, Inc. ' Company Statement 28
Enzo Biochem, Inc. ' Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Enzo Biochem, Inc., Recent Developments 33
Enzo Biochem, Inc.- Press Release 33
Nov 17, 2009: Enzo Biochem announces that it is ready to reveal EGS21 data 33
Nov 02, 2009: Enzo Biochem Announces Results Of EGS21 Clinical Trial For Treatment Of Non-Alcoholic Steatohepatitis 33
Sep 23, 2009: NIH and Enzo Biochem To Conduct Clinical Trial With Optiquel 34
Jun 04, 2009: Data From Enzo Therapeutics' Phase II Study Of Crohn's Disease Of Alequel Presented At Prestigious
Gastroenterology Conference 34
Financial Deals Landscape 36
Enzo Biochem, Inc., Deals Summary 36
Enzo Biochem, Inc., Pharmaceuticals & Healthcare, Deal Details 37
Partnerships 37
Enzo Clinical Enters Into Co-Marketing Agreement With IncellDx 37
Enzo Biochem Enters Into An Agreement With MultiGEN Diagnostics 38
Enzo Clinical Labs Enters Into Co-Marketing Agreement With Ikonisys 39
Enzo Biochem Enters Into An Agreement With GeneNews 40
Enzo Life Sciences Enters Into Co-Marketing Agreement With BioTek Instruments 41
Enzo Biochem Enters Into Co-Development Agreement With National Institutes of Health 42
Licensing Agreements 43
Enzo Life Sciences Enters Into Agreement With Abbott Labs 43
Enzo Biochem Enters Into Licensing Agreement With LBS Technologies 44
Equity Offering 45
Enzo Biochem Files Registration Statement For Public Offering Of $50 Million 45
Enzo Biochem Completes Private Placement Of $15 Million 47
Acquisition 51
Enzo Biochem Acquires Assay Designs 51
Enzo Biochem Acquires BIOMOL International 53
Enzo Life Sciences Acquires 10 P's 55



Enzo Life Sciences Acquires Axxora Life Sciences 56
Appendix 57
Methodology 57
Coverage 57
Secondary Research 57
Primary Research 57
Expert Panel Validation 57
Contact Us 58
Disclaimer 58

List of Tables

Enzo Biochem, Inc., Key Information 6
Enzo Biochem, Inc., Key Facts 6
Enzo Biochem, Inc. ' Pipeline by Indication, 2012 8
Enzo Biochem, Inc. ' Pipeline by Stage of Development, 2012 9
Enzo Biochem, Inc. ' Monotherapy Products in Pipeline, 2012 10
Enzo Biochem, Inc. ' Phase II, 2012 11
Enzo Biochem, Inc. ' Pre-Clinical, 2012 12
Enzo Biochem, Inc. ' Discovery, 2012 13
Enzo Biochem, Inc. ' Pipeline By Therapeutic Class, 2012 23
Enzo Biochem, Inc. ' Pipeline By Route of Administration, 2012 24
Enzo Biochem, Inc. ' Recent Pipeline Updates, 2012 25
Enzo Biochem, Inc. - Dormant Developmental Projects,2012 26
Enzo Biochem, Inc. - Discontinued Pipeline Products, 2012 27
Enzo Biochem, Inc., Other Locations 31
Enzo Biochem, Inc., Subsidiaries 32
Enzo Biochem, Inc., Deals Summary 36
Enzo Clinical Enters Into Co-Marketing Agreement With IncellDx 37
Enzo Biochem Enters Into An Agreement With MultiGEN Diagnostics 38
Enzo Clinical Labs Enters Into Co-Marketing Agreement With Ikonisys 39
Enzo Biochem Enters Into An Agreement With GeneNews 40
Enzo Life Sciences Enters Into Co-Marketing Agreement With BioTek Instruments 41
Enzo Biochem Enters Into Co-Development Agreement With National Institutes of Health 42
Enzo Life Sciences Enters Into Agreement With Abbott Labs 43
Enzo Biochem Enters Into Licensing Agreement With LBS Technologies 44
Enzo Biochem Files Registration Statement For Public Offering Of $50 Million 45
Enzo Biochem Acquires Assay Designs 51
Enzo Biochem Acquires BIOMOL International 53
Enzo Life Sciences Acquires 10 P's 55
Enzo Life Sciences Acquires Axxora Life Sciences 56

List of Figures

Enzo Biochem, Inc. ' Pipeline by Indication, 2012 8
Enzo Biochem, Inc. ' Pipeline by Stage of Development, 2012 9



Enzo Biochem, Inc. ' Monotherapy Products in Pipeline, 2012 10
Enzo Biochem, Inc. ' Pipeline By Therapeutic Class, 2012 23


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 1 500.00 Quantity: _____

Site License--USD 3 000.00 Quantity: _____

Corporate License--USD 4 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Enzo Biochem, Inc. ' Product Pipeline Review ' 2012

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Andere mochten auch

Andere mochten auch (8)

Mehr von ReportLinker.com

Mehr von ReportLinker.com (20)

Enzo Biochem, Inc. ' Product Pipeline Review ' 2012